Post-approval studies (Phase 4)Study completedNCT01054976
What this trial is testing
The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease
Who this might be right for
Alzheimer's Disease
Janssen Korea, Ltd., Korea 99